Enoxaparin renal dose adjustment


Objectives This study was designed to examine a unique and low dose of intravenous enoxaparin in elective percutaneous coronary intervention (PCI) that would be applicable to an unselected population regardless of age, weight, renal function, or use of glycoprotein IIb/IIIa inhibitors. Background There is limited experience of anticoagulation using intravenous (IV) low-molecular-weight heparin ... (agreed with renal clinicians to use Enoxaparin 20mg s/c OD) - Pregnancy (refer to RCOG guidelines and BNF for dosing ) - Obesity (i.e. >160mg doses of enoxaparin) - High bleed risk - Metallic mechanical heart valves - Low platelets <75 x10 9/L - Liver impairment (no dose adjustment is recommended; anti-Xa monitoring in Jun 14, 2019 · Lovenox is a clear, colorless to pale yellow sterile solution, and as with other parenteral drug products, should be inspected visually for particulate matter and discoloration prior to administration. Use a tuberculin syringe or equivalent when using Lovenox multiple-dose vials to assure withdrawal of the appropriate volume of drug.